M&T Bank’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

M&T Bank’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,118	Closed	-$181K	–	1673
2017 Q4	$181K	Hold	10,118	–	–	﹤0.01%	1447
2017 Q3	$120K	Buy	+10,118	New	+$114K	﹤0.01%	1476

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

M&T Bank's SCMP Position: Q1 2018 in Review

M&T Bank sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 10,118 shares — an estimated $181K sold.

M&T Bank first reported a position in SCMP in Q3 2017 and held it in 2 quarters. The position peaked at $181K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

M&T Bank reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
M&T Bank sold 10,118 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $181K.
M&T Bank first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2017 and held it in 2 quarters.
M&T Bank's Sucampo Pharmaceuticals, Inc. position peaked at $181K in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on M&T Bank's 13F filing for Q1 2018, filed 4 May 2018.